Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Jul 1, 2022

Accession no.
0001209191-22-040099
Filed
Jul 1, 2022
Trade date
Jun 1-30, 2022
Filing delay
30 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $5.55K. It was filed 30 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 1, 2022Common StockPPurchaseAcquired+127$2.05+$260.35187,744Direct
Jun 2, 2022Common StockPPurchaseAcquired+127$2.08+$264.16187,871Direct
Jun 3, 2022Common StockPPurchaseAcquired+127$2.09+$265.43187,998Direct
Jun 6, 2022Common StockPPurchaseAcquired+136$2.07+$281.52188,134Direct
Jun 7, 2022Common StockPPurchaseAcquired+100$2.08+$208188,234Direct
Jun 8, 2022Common StockPPurchaseAcquired+136$2.12+$288.32188,370Direct
Jun 9, 2022Common StockPPurchaseAcquired+136$2.09+$284.24188,506Direct
Jun 10, 2022Common StockPPurchaseAcquired+136$2.04+$277.44188,642Direct
Jun 13, 2022Common StockPPurchaseAcquired+136$2.01+$273.36188,778Direct
Jun 14, 2022Common StockPPurchaseAcquired+136$2.02+$274.72188,914Direct
Jun 15, 2022Common StockPPurchaseAcquired+136$1.98+$269.28189,050Direct
Jun 16, 2022Common StockPPurchaseAcquired+136$1.95+$265.2189,186Direct
Jun 17, 2022Common StockPPurchaseAcquired+136$1.94+$263.84189,322Direct
Jun 21, 2022Common StockPPurchaseAcquired+143$1.97+$281.71189,465Direct
Jun 22, 2022Common StockPPurchaseAcquired+139$1.99+$276.61189,604Direct
Jun 23, 2022Common StockPPurchaseAcquired+143$2.01+$287.43189,747Direct
Jun 24, 2022Common StockPPurchaseAcquired+143$2.11+$301.73189,890Direct
Jun 27, 2022Common StockPPurchaseAcquired+26$2.06+$53.56189,916Direct
Jun 28, 2022Common StockPPurchaseAcquired+132$2.06+$271.92190,048Direct
Jun 29, 2022Common StockPPurchaseAcquired+143$2.11+$301.73190,191Direct
Jun 30, 2022Common StockPPurchaseAcquired+143$2.08+$297.44190,334Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)